NasdaqCM - Nasdaq Real Time Price USD

Korro Bio, Inc. (KRRO)

15.56
+0.16
+(1.04%)
At close: May 9 at 4:00:00 PM EDT
15.56
0.00
(0.00%)
After hours: May 9 at 4:05:07 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
2,271
2,271
0
0
0
Operating Expense
94,181
94,181
84,534
58,998
35,494
Operating Income
-91,910
-91,910
-84,534
-58,998
-35,494
Net Non Operating Interest Income Expense
--
--
--
829
--
Other Income Expense
8,470
8,470
3,389
976
13,537
Pretax Income
-83,440
-83,440
-81,145
-58,022
-21,957
Tax Provision
141
141
27
10
2
Net Income Common Stockholders
-83,581
-83,581
-81,172
-58,032
-21,959
Diluted NI Available to Com Stockholders
-83,581
-83,581
-81,172
-58,032
-21,959
Basic EPS
-9.37
--
-53.08
-7.25
-2.74
Diluted EPS
-9.37
--
-53.08
-7.25
-2.74
Basic Average Shares
8,920.56
--
1,529.32
8,001.28
8,001.28
Diluted Average Shares
8,920.56
--
1,529.32
8,001.28
8,001.28
Total Operating Income as Reported
-91,910
-91,910
-84,534
-58,998
-35,494
Total Expenses
94,181
94,181
84,534
58,998
35,494
Net Income from Continuing & Discontinued Operation
-83,581
-83,581
-81,172
-58,032
-21,959
Normalized Income
-83,581
-83,581
-81,172
-58,032
-21,959
Interest Income
--
--
--
947
--
Interest Expense
--
--
--
118
--
Net Interest Income
--
--
--
829
--
EBIT
-91,910
-91,910
-84,534
-58,998
-35,494
EBITDA
-88,345
-88,345
-80,904
-56,487
-33,899
Reconciled Depreciation
3,565
3,565
3,630
2,511
1,595
Net Income from Continuing Operation Net Minority Interest
-83,581
-83,581
-81,172
-58,032
-21,959
Normalized EBITDA
-88,345
-88,345
-80,904
-56,487
-33,899
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
12/31/2021 - 10/3/2019

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

WVE Wave Life Sciences Ltd.
6.59
+0.69%
 
PRQR ProQR Therapeutics N.V.
1.6100
+3.87%
 
DYN Dyne Therapeutics, Inc.
11.41
+1.02%
 
DSGN Design Therapeutics, Inc.
3.5000
-0.57%
 
VRDN Viridian Therapeutics, Inc.
12.39
-3.05%
 
IFRX InflaRx N.V.
1.6100
+1.90%
 
FULC Fulcrum Therapeutics, Inc.
5.37
-0.74%
 
IRON Disc Medicine, Inc.
44.24
-0.11%
 
BOLD Boundless Bio, Inc.
1.4400
-4.00%
 
NGNE Neurogene Inc.
14.73
-1.80%